Versameb AG: Versameb Announces Publication in Molecular Therapy - Nucleic Acids Journal Demonstrating the Potential of Engineered IGF-I mRNA as a Regenerative Therapeutic finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Versameb AG ("Versameb"), a pre-clinical stage company focused on discovering and developing innovative RNA-based therapeutics, today announces.
/PRNewswire/ Versameb AG ("Versameb"), a pre-clinical stage company focused on discovering and developing innovative RNA-based therapeutics, today announces.
- Data demonstrates first-in-class potential as a regenerative treatment of Stress Urinary Incontinence - Treatment results in muscle regeneration with restored functionality in pre-clinical
/PRNewswire/ Versameb AG ("Versameb"), a pre-clinical stage company focused on discovering and developing innovative RNA-based drugs, today announces that.